<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="109206">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01834664</url>
  </required_header>
  <id_info>
    <org_study_id>00109</org_study_id>
    <nct_id>NCT01834664</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of Bone Marrow Derived Autologous Cells Treatment of Cerebral Palsy in Subjects Above 15 Years</brief_title>
  <acronym>BMACCP</acronym>
  <official_title>Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Cerebral Palsy in Subjects Above Years (BMACCP)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chaitanya Hospital, Pune</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chaitanya Hospital, Pune</source>
  <oversight_info>
    <authority>India: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This Study is Single arm, Single Centre trial to study the safety and efficacy of bone
      marrow derived autologous mononuclear cells (100 millions per dose)study enrollment duration
      36 months sample size 100 patients should be treated (above 15 years of age) with cerebral
      palsy in India. Primary outcome measures are improvement in walking ability and kinetic gait
      pattern.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cerebral Palsy is commonest cause of Disability in India and south East Asia. This Study is
      devised to quantify the safety and efficacy of bone marrow derived autologous mononuclear
      cells(100 millions per dose)study enrolment duration 36 months sample size 100 patients
      should be treated (above 15 years of age) with cerebral palsy, in India. Primary outcome
      measures are improvement in walking ability and kinetic gait pattern as per as various
      clinical scales and also changes in the brain.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Anticipated">April 2014</completion_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Improvement in muscle rigidity using Ash worth scale</measure>
    <time_frame>6 Months</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement in dysregulated phospholipid Metabolism</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement in walking ability and kinetic gait Pattern</measure>
    <time_frame>6 Months</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement in overall motor control using oxford scale</measure>
    <time_frame>6 Months</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement in orbitoFrontal-amygdala circuit and self-regulation of social -emotional behaviour</measure>
    <time_frame>6 month</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement in motor-linked implicit learning</measure>
    <time_frame>6 month</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Ataxic Infantile Cerebral Palsy</condition>
  <arm_group>
    <arm_group_label>STEM CELL</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Transfer of autologous stem cell [MNCs ]intrathecally</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>stem cell (MNCs )</intervention_name>
    <description>Intra thecal transplantation of autologous stem cell [MNCs ]Per dose at the interval</description>
    <arm_group_label>STEM CELL</arm_group_label>
    <other_name>Intra thecal autologous stem cell MNCs</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject aged above  15 years with a diagnosis of Cerebral Palsy. Regional Nerve
             damage as shown by Magnetic Resonance Imaging(MRI)

          -  Patient suffer from cerebral palsy due to prenatal and postnatal cause,

          -  Willing to undergoing Bone Marrow derived autologous stem cell therapy.

          -  Able to Comprehend and give written informed consent form for the study

          -  willing to come to the hospital for follow up visits as per the protocol requirements

        Exclusion Criteria:

          -  History of meningitis,meningoencephalitis  , epilepsy or life threatening allergic or
             immune -mediated reaction

          -  Hemodynamically unstable patients

          -  history of or concurrent autoimmune disease or acute episode if Guillain- barre
             syndrome

          -  peripheral Muscular dystrophy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ANANT E BAGUL, M.S</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHAITANYA HOSPITAL</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sachin S Jamadar, Dortho</last_name>
    <phone>+918888788880</phone>
    <email>sac2751982@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Smita S Bhoyar, B.A.M.S.PGCR</last_name>
    <phone>9372620569</phone>
    <email>drsmitabhoyar@rediff.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chaitanya Hospital</name>
      <address>
        <city>Pune</city>
        <state>Maharashtra</state>
        <zip>411009</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sachin S Jamadar, MBBS.DOrtho</last_name>
      <phone>8888788880</phone>
      <email>sac2751982@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Smita S Bhoyar, BAMSPGCR</last_name>
      <phone>9372620569</phone>
      <email>drsmitabhoyar@rediffmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Anant E Bagul, M.S.Ortho</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>April 16, 2013</lastchanged_date>
  <firstreceived_date>April 8, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chaitanya Hospital, Pune</investigator_affiliation>
    <investigator_full_name>Dr. Sachin Jamadar</investigator_full_name>
    <investigator_title>CO-Investigator</investigator_title>
  </responsible_party>
  <keyword>Ataxic Infantile Cerebral Palsy stem cell therapy</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cerebral Palsy</mesh_term>
    <mesh_term>Paralysis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
